Get all your news in one place.
100's of premium titles.
One app.
Start reading
Salon
Salon
Lifestyle
Joy Saha

How Ozempic could boost the US economy

More Americans taking popular medications used for weight loss, including Ozempic and Wegovy, could benefit the national economy in the future, Goldman Sachs analysts predicted in a recent research report.

Both Ozempic and Wegovy are classified as GLP-1 agonists, a diabetes medication that gained popularity online and among celebrities as an anti-obesity drug. According to a 2023 analysis reported by NBC News, U.S. health care providers wrote more than nine million prescriptions for Ozempic, Wegovy and similar diabetes and obesity drugs during the last three months of 2022. Quarterly prescriptions for those drugs increased 300% between early 2020 and the end of 2022. Ozempic is not approved for weight loss by regulators. However, semaglutide is approved for weight loss under the brand name Wegovy.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.